U.S. Markets open in 2 hrs 8 mins

Mera Pharmaceuticals, Inc. (MRPI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00130.0000 (0.0000%)
At close: 3:26PM EDT
People also watch

Mera Pharmaceuticals, Inc.

18331 Pines Boulevard
Suite 273
Pembroke Pines, FL 33029
United States

Full Time Employees4

Key Executives

Mr. Gregory F. KowalChief Exec. Officer and Chief Exec. Officer of Consumer Products DivisionN/AN/A68
Dr. Michael F. Corcoran Ph.D.Pres and Director of Sales & MarketingN/AN/A67
Mr. Lawrence Harris WolfeChief Financial Officer, VP of Fin. and DirectorN/AN/A54
Ms. Melanie K. KelekolioGen. Mang. of The Operations & Production Facility and VPN/AN/A49
Mr. Kenneth I. CrowderChief Operating Officer of the Consumer Products DivisionN/AN/A78
Amounts are as of December 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Mera Pharmaceuticals, Inc. primarily develops and commercializes natural products derived principally from microalgae using its patented photobioreactor technology. It produces various substances and bioactive compounds that have applications in a range of commercial areas, including human nutrition, pharmaceuticals, and other commodities, such as bio-diesel. The company’s products include ASTAFACTOR, a nutraceutical and source of natural astaxanthin; SALMON ESSENTIALS, a combination of astaxanthin and omega-3 fatty acids; and KONA SEA SALT. It markets its products to mass retail outlets in Hawaii through distribution arrangements with companies. The company also operates a chain of professional martial arts studios. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Pembroke Pines, Florida.

Corporate Governance

Mera Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.